143 related articles for article (PubMed ID: 22086405)
1. Degree of freezing does not affect efficacy of frozen gloves for prevention of docetaxel-induced nail toxicity in breast cancer patients.
Ishiguro H; Takashima S; Yoshimura K; Yano I; Yamamoto T; Niimi M; Yamashiro H; Ueno T; Takeuchi M; Sugie T; Yanagihara K; Toi M; Fukushima M
Support Care Cancer; 2012 Sep; 20(9):2017-24. PubMed ID: 22086405
[TBL] [Abstract][Full Text] [Related]
2. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand.
Scotté F; Tourani JM; Banu E; Peyromaure M; Levy E; Marsan S; Magherini E; Fabre-Guillevin E; Andrieu JM; Oudard S
J Clin Oncol; 2005 Jul; 23(19):4424-9. PubMed ID: 15994152
[TBL] [Abstract][Full Text] [Related]
3. Cryotherapy for docetaxel-induced hand and nail toxicity: randomised control trial.
McCarthy AL; Shaban RZ; Gillespie K; Vick J
Support Care Cancer; 2014 May; 22(5):1375-83. PubMed ID: 24362908
[TBL] [Abstract][Full Text] [Related]
4. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
Can G; Aydiner A; Cavdar I
Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
[TBL] [Abstract][Full Text] [Related]
5. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Scotté F; Banu E; Medioni J; Levy E; Ebenezer C; Marsan S; Banu A; Tourani JM; Andrieu JM; Oudard S
Cancer; 2008 Apr; 112(7):1625-31. PubMed ID: 18286527
[TBL] [Abstract][Full Text] [Related]
6. Multicenter randomized controlled trial to evaluate the efficacy and tolerability of frozen gloves for the prevention of chemotherapy-induced peripheral neuropathy.
Beijers AJM; Bonhof CS; Mols F; Ophorst J; de Vos-Geelen J; Jacobs EMG; van de Poll-Franse LV; Vreugdenhil G
Ann Oncol; 2020 Jan; 31(1):131-136. PubMed ID: 31912787
[TBL] [Abstract][Full Text] [Related]
7. Taxan-associated nail toxicity.
Doleschal B; Petzer A; Aichberger KJ
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28143862
[No Abstract] [Full Text] [Related]
8. Evaluation of Prevention Interventions for Taxane-Induced Dermatologic Adverse Events: A Systematic Review.
Marks DH; Qureshi A; Friedman A
JAMA Dermatol; 2018 Dec; 154(12):1465-1472. PubMed ID: 30383138
[TBL] [Abstract][Full Text] [Related]
9. [Examination about the influence for daily life that nail and skin disorders induced by docetaxel in patients with breast cancer].
Kohama K; Masuda N; Yamamura J; Ishitobi M; Masuda H; Ogawa M; Todaka K; Tanaka T; Ueno H; Nakamori S; Tsujinaka T
Gan To Kagaku Ryoho; 2009 Apr; 36(4):615-8. PubMed ID: 19381034
[TBL] [Abstract][Full Text] [Related]
10. Final results of a phase II clinical trial of weekly docetaxel in combination with capecitabine in anthracycline-pretreated metastatic breast cancer.
Mackey JR; Tonkin KS; Koski SL; Scarfe AG; Smylie MG; Joy AA; Au HJ; Bodnar DM; Soulieres D; Smith SW
Clin Breast Cancer; 2004 Oct; 5(4):287-92. PubMed ID: 15507175
[TBL] [Abstract][Full Text] [Related]
11. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
Yorulmaz A; Dogan M; Artuz F; Zengin N
Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
[TBL] [Abstract][Full Text] [Related]
12. Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer.
Coolbrandt A; Vancoille K; Dejaeger E; Peeters H; Laenen A; Neven P; Punie K; Wildiers H
Breast Cancer Res Treat; 2022 Apr; 192(2):293-301. PubMed ID: 34982322
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer.
Connolly RM; Rudek MA; Garrett-Mayer E; Jeter SC; Donehower MG; Wright LA; Zhao M; Fetting JH; Emens LA; Stearns V; Davidson NE; Baker SD; Wolff AC
Breast Cancer Res Treat; 2011 May; 127(1):153-62. PubMed ID: 21350820
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
Roh MR; Cho JY; Lew W
Yonsei Med J; 2007 Feb; 48(1):124-6. PubMed ID: 17326255
[TBL] [Abstract][Full Text] [Related]
15. Subungueal haemorrhages following docetaxel (taxotere) treatment.
Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
[TBL] [Abstract][Full Text] [Related]
16. Bi-weekly docetaxel in the adjuvant treatment of node-positive or high-risk breast cancer patients: phase I study of the Shiga Breast Cancer Study Group.
Abe H; Ogawa H; Okino T; Kato M; Sako H; Sano H; Shimomatsuya T; Suwa H; Higashide S
Breast Cancer; 2009; 16(1):37-41. PubMed ID: 18493840
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of ramucirumab in combination with docetaxel in Japanese patients with locally advanced or metastatic breast cancer: a Phase Ib study.
Masuda N; Iwata H; Aogi K; Xu Y; Ibrahim A; Gao L; Dalal R; Yoshikawa R; Sasaki Y
Jpn J Clin Oncol; 2016 Dec; 46(12):1088-1094. PubMed ID: 27608646
[TBL] [Abstract][Full Text] [Related]
18. Improvement in docetaxel-induced nail changes associated with cyclooxygenase-2 inhibitor treatment.
Nakamura S; Kajita S; Takagi A; Hashimoto Y; Ishida-Yamamoto A; Takahashi H; Iizuka H
Clin Exp Dermatol; 2009 Oct; 34(7):e320-1. PubMed ID: 19456779
[No Abstract] [Full Text] [Related]
19. A phase II study of escalated-dose docetaxel with granulocyte colony-stimulating factor support in patients with advanced breast cancer.
Mitchell PL; Basser R; Chipman M; Grigg A; Mansfield R; Cebon J; Davis ID; Appia F; Green M
Ann Oncol; 2004 Apr; 15(4):585-9. PubMed ID: 15033663
[TBL] [Abstract][Full Text] [Related]
20. Frostbite as a complication of frozen gloves in the prevention of docetaxel-induced onycholysis.
Begon E; Blum L; Fraboulet G; Assouad S; Bachmeyer C
Eur J Dermatol; 2011; 21(4):628-9. PubMed ID: 21697040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
